SPONSOR
Shanghai Zhongshan Hospital
Total Trials
17
Recruiting
17
Phases
EARLY_Phase 1, Phase 2, Phase 4, Phase 2, Phase 3, Phase 3
Conditions studied: Androgenetic Alopecia (AGA)Gastric CancerGastroEsophageal CancerSepsisIntra-Abdominal InfectionsLiver CancerMetastatic Liver CancerRectal CancerTakayasu ArteritisTocilizumab
NCT07012486 EARLY_Phase 1
Recruiting
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
Androgenetic Alopecia (AGA)
NCT06468280 Phase 2
Recruiting
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
Gastric Cancer
NCT07172451 Phase 4
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
Sepsis
NCT05913141
Recruiting
PDO/PDO-TIL/PDOTS for Drug Screen
Liver Cancer
NCT05563922 Phase 2
Recruiting
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
Rectal Cancer
NCT04300686 Phase 4
Recruiting
A Pilot Study in Severe Patients With Takayasu Arteritis.
Takayasu Arteritis
NCT05380622
Recruiting
CHART Study of Coronary CT Angiography in Coronary Artery Disease
Coronary Artery Disease
NCT07333677 EARLY_Phase 1
Recruiting
In Vivo CAR-T for Refractory Graves' Disease
Graves' Disease
NCT04973306 Phase 2, Phase 3
Recruiting
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma Stage II
NCT06253962
Recruiting
Carotid Atherosclerosis in Predicting Coronary Artery Disease
Carotid Atherosclerosis
NCT07261345 EARLY_Phase 1
Recruiting
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
Graves' Disease
NCT06605794
Recruiting
FreeFlow Percutaneous Atrial Septal Shunt for IPAH
Pulmonary Arterial Hypertension
NCT06662630
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in Mechanical Ventilation Patients
Atelectasis
NCT07169201
Recruiting
High-Resolution CT for Heart
Coronary Artery Disease
NCT07054086
Recruiting
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Esophageal Cancer
NCT07277114
Recruiting
DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR
Coronary Calcification
NCT07309289 Phase 3
Recruiting
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)